MAO Unveiled
An exploration of Monoamine Oxidase (MAO), the critical enzymes involved in neurotransmitter metabolism and their profound implications in neurological and psychiatric health.
What is MAO? ๐ Clinical Relevance โ๏ธDive in with Flashcard Learning!
๐ฎ Play the Wiki2Web Clarity Challenge Game๐ฎ
Defining Monoamine Oxidase
Enzymatic Function
Monoamine oxidases (MAOs), classified under EC 1.4.3.4, are a family of enzymes responsible for catalyzing the oxidative deamination of monoamines. This process involves the oxidation of monoamines, utilizing oxygen to cleave the amine group. They are integral components of the flavin-containing amine oxidoreductase protein family.
Cellular Localization
MAOs are primarily located on the outer mitochondrial membrane in most cell types throughout the body. This strategic positioning allows them to efficiently metabolize monoamines, both those ingested through diet and endogenous neurotransmitters.
Historical Context
The first MAO enzyme was identified in 1928 by Mary Bernheim in liver tissue and was initially named tyramine oxidase. Its discovery marked a significant step in understanding metabolic pathways involving amines.
Identification
Key identifiers for Monoamine Oxidase include:
Identifier | Value |
---|---|
EC Number | 1.4.3.4 |
CAS Number | 9001-66-5 |
Pfam | PF01593 |
InterPro | IPR001613 |
MAO Subtypes and Distribution
MAO-A
Monoamine oxidase A (MAO-A) is predominantly involved in the catabolism of neurotransmitters such as serotonin, norepinephrine, and epinephrine. It is expressed in neurons and glia, as well as in the liver, pulmonary vascular endothelium, gastrointestinal tract, and placenta. MAO-A levels reach adult concentrations shortly after birth.
MAO-B
Monoamine oxidase B (MAO-B) primarily metabolizes phenethylamine and benzylamine. While also found in neurons and glia, it is predominantly localized in blood platelets outside the central nervous system. MAO-B activity increases with age, particularly in the brain and pineal gland.
Tissue Distribution
Both MAO-A and MAO-B exhibit distinct regional distributions within the brain. High levels of both are found in the hypothalamus and hippocampal uncus. The striatum and globus pallidus show high MAO-B activity with minimal MAO-A, whereas the cortex has higher MAO-A levels, with exceptions in the cingulate cortex.
Mechanism of Action
Oxidative Deamination
MAOs catalyze oxidative deamination. The process begins with the oxidation of the substrate by the flavin adenine dinucleotide (FAD) cofactor, generating a reduced FADH2 form. The resulting imine intermediate is then hydrolyzed non-enzymatically into an aldehyde and ammonia. Molecular oxygen is required to regenerate the active FAD cofactor.
Structural Homology
MAO-A and MAO-B share approximately 70% structural similarity. Their substrate binding sites are largely hydrophobic. Key tyrosine residues within these sites are hypothesized to play a role in substrate orientation and inhibitor interactions, potentially linking to mental health conditions.
Novel Roles of MAO-B
Recent findings suggest MAO-B's role extends beyond neurotransmitter breakdown. In rodents, MAO-B participates in striatal GABA synthesis from putrescine, influencing dopaminergic neuron activity. This pathway, mediated by MAO-B in astrocytes, is observed across various brain regions and may necessitate a re-evaluation of MAO-B inhibitor therapies for conditions like Parkinson's disease.
Substrates and Specificities
MAO-A Substrates
MAO-A preferentially catabolizes:
- Serotonin
- Norepinephrine
- Epinephrine
- Tryptamine
- Tyramine
- Dopamine
MAO-A inhibitors are primarily used as antidepressants and anti-anxiety agents.
MAO-B Substrates
MAO-B preferentially catabolizes:
- Phenethylamine
- Benzylamine
- Tryptamine
- Tyramine
- Dopamine
MAO-B inhibitors are utilized in managing Parkinson's disease and Alzheimer's disease.
Exogenous Compounds
Beyond endogenous monoamines, MAOs metabolize numerous exogenous compounds and drugs. These include various sympathomimetics, sympatholytics, serotonergic agents (e.g., DMT, sumatriptan), and other pharmaceuticals like citalopram, nomifensine, and sertraline. Some drugs, like haloperidol, may form neurotoxic metabolites via MAO activity.
Clinical Significance
MAO Activity and Disease
Dysregulation of MAO activity (either excessive or deficient) is implicated in various psychiatric and neurological disorders. Altered MAO levels have been associated with schizophrenia, depression, attention deficit disorders, substance abuse, and migraines. MAO-A inhibitors are prescribed for depression, while MAO-B inhibitors are used for neurodegenerative diseases.
MAOI Interactions
Monoamine oxidase inhibitors (MAOIs) require careful management due to potential interactions. Excessive levels of catecholamines (epinephrine, norepinephrine, dopamine) can precipitate a hypertensive crisis, while excessive serotonin can lead to serotonin syndrome. Dietary restrictions (avoiding tyramine-rich foods) are crucial when using MAO-A inhibitors.
Parasites and Insects
MAO activity is relevant in host-parasite interactions. For instance, trypanosomes causing sleeping sickness disrupt MAO activity in the orexin system, affecting sleep patterns. Furthermore, certain insecticides function by inhibiting insect MAOs, highlighting the enzyme's conserved biological importance.
Genetic Basis of MAO
Gene Location and Polymorphisms
The genes encoding MAO-A and MAO-B are located adjacently on the X chromosome (Xp11.4-p11.3). They exhibit significant sequence similarity. Rare mutations in the MAO-A gene are linked to Brunner syndrome. Promoter region polymorphisms, particularly the low-activity variant of MAO-A, have been studied in relation to antisocial behavior, although findings suggest environmental factors (maltreatment) play a more significant role, and genetic predisposition may be inherited alongside abusive environments.
Behavior and Genetics
Research suggests a potential link between MAO-A gene variants and personality traits like novelty seeking. Variations in MAO-A gene frequencies exist across different ethnic groups. The popular press has termed certain variants the "warrior gene," though this requires careful interpretation due to the complex interplay of genetics and environment.
MAO Activity and Aging
Age-Related Changes
Unlike many enzymes, MAO-B activity demonstrates an increase with age in mammalian brains, including humans. This phenomenon is also observed in the pineal gland of aging rats. The elevated MAO-B activity may contribute to reduced monoamine levels observed in the aged brain and pineal gland.
Teacher's Corner
Edit and Print this course in the Wiki2Web Teacher Studio

Click here to open the "Monoamine Oxidase" Wiki2Web Studio curriculum kit
Use the free Wiki2web Studio to generate printable flashcards, worksheets, exams, and export your materials as a web page or an interactive game.
True or False?
Test Your Knowledge!
Gamer's Corner
Are you ready for the Wiki2Web Clarity Challenge?

Unlock the mystery image and prove your knowledge by earning trophies. This simple game is addictively fun and is a great way to learn!
Play now
References
References
Feedback & Support
To report an issue with this page, or to find out ways to support the mission, please click here.
Academic Disclaimer
Important Notice
This document was generated by an AI acting as a Professional PhD Professor, synthesizing information from publicly available data sources. It is intended strictly for academic and educational purposes at a postgraduate level.
This is not medical advice. The content herein should not substitute for professional medical consultation, diagnosis, or treatment. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment. Reliance on any information provided in this document is solely at your own risk.
The creators of this content are not liable for any errors, omissions, or actions taken based on the information presented. Ensure verification against primary sources and consult with experts for critical applications.